A murine model for pulmonary aspergillosis
Gordee, R.S.; Zeckner, D.J.; Jones, K.A.; Engelhardt, J.A.
Abstracts of the Annual Meeting of the American Society for Microbiology 90: 76
1990
ISSN/ISBN: 0094-8519 Accession: 029686320
PDF emailed within 1 workday: $29.90
Related References
Sheppard, D.C.; Rieg, G.; Chiang, L.Y.; Filler, S.G.; Edwards, J.E.; Ibrahim, A.S. 2004: Novel inhalational murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 48(5): 1908-1911Sheppard, D.C.; Graybill, J.R.; Najvar, L.K.; Chiang, L.Y.; Doedt, T.; Kirkpatrick, W.R.; Bocanegra, R.; Vallor, A.C.; Patterson, T.F.; Filler, S.G. 2006: Standardization of an experimental murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 50(10): 3501-3503
Szigeti, Z.M.; Talas, L.; Palicz, Z.; Szentesi, P.; Hargitai, Z.; Csernoch, L.; Balla, J.; Pocsi, I.; Banfalvi, G.; Szeman-Nagy, G. 2018: Murine model to follow hyphal development in invasive pulmonary aspergillosis Applied Microbiology and Biotechnology 102(6): 2817-2825
Clemons, K.V.; Schwartz, J.A.; Stevens, D.A. 2011: Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis Medical Mycology 49(8): 834-847
Chiang, L.Y.; Ejzykowicz, D.E.; Tian, Z.-Q.; Katz, L.; Filler, S.G. 2006: Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 50(10): 3464-3466
Grahl, N.; Kowalski, C.H.; Cramer, R.A. 2021: Detection of Low Oxygen Microenvironments in a Murine Model of Invasive Pulmonary Aspergillosis Using Pimonidazole Methods in Molecular Biology 2260: 197-205
Madan, T.; Kishore, U.; Singh, M.; Strong, P.; Hussain, E.M.; Reid, K.B.; Sarma, P.U. 2001: Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis Infection and Immunity 69(4): 2728-2731
Saini, S.; Poelmans, J.; Korf, H.; Dooley, J.L.; Liang, S.; Manshian, B.B.; Verbeke, R.; Soenen, S.J.; Vande Velde, G.; Lentacker, I.; Lagrou, K.; Liston, A.; Gysemans, C.; De Smedt, S.C.; Himmelreich, U. 2019: Longitudinal In Vivo Assessment of Host-Microbe Interactions in a Murine Model of Pulmonary Aspergillosis Iscience 20: 184-194
Wickstrom, A.M.; Dalton, M.N.; Allen, S.D. 1990: Interactions of cortisone acetate and aspergillus fumigatus in a murine model of experimental pulmonary aspergillosis Abstracts of the Annual Meeting of the American Society for Microbiology 90: 76
Takemoto, K.; Yamamoto, Y.; Ueda, Y.; Kanazawa, K.; Yoshida, K.; Niki, Y. 2009: Comparative study on the efficacy of liposomal amphotericin B and voriconazole in a murine pulmonary aspergillosis model ChemoTherapy 55(2): 105-113
Mondon, P.; De Champs, C.; Donadille, A.; Ambroise-Thomas, P.; Grillot, R. 1996: Variation in virulence of Aspergillus fumigatus strains in a murine model of invasive pulmonary aspergillosis Journal of Medical Microbiology 45(3): 186-191
Kaur, S.; Gupta, V.K.; Thiel, S.; Sarma, P.U.; Madan, T. 2007: Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis Clinical and Experimental Immunology 148(2): 382-389
Nawada, R.; Amitani, R.; Tanaka, E.; Niimi, A.; Suzuki, K.; Murayama, T.; Kuze, F. 1996: Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection Journal of Clinical Microbiology 34(6): 1433-1439
Wiederhold, N.P.; Kontoyiannis, D.P.; Chi, J.; Prince, R.A.; Tam, V.H.; Lewis, R.E. 2004: Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity Journal of Infectious Diseases 190(8): 1464-1471
Olson, J.A.; Adler-Moore, J.P.; Schwartz, J.; Jensen, G.M.; Proffitt, R.T. 2006: Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model Antimicrobial Agents and ChemoTherapy 50(6): 2122-2131